The glossary explains some of the words used across this website and covers some key cancer and research terms, which primarily focus on lung cancer.

Genomic profiling

A type of precision medicine that uses the genetic profile of a tumour to assess cancer subtype and classification, allowing for more targeted and effective treatments.1 See also ‘precision medicine’

Guideline-concordant care

Care that provides patients with the minimal treatment as defined by national guidelines.2 See also ‘guidelines’


Accredited organisations often publish best-practice guidelines that healthcare professionals may refer to when set-up of an intervention. These tend to be a robust, evidence-based and a formally agreed upon set of recommended criteria, protocols or classification systems for the clinical management of a disease.3 See also ‘Incidental nodule management protocol’


  1. Chakravarty D, Solit DB. 2021. Clinical cancer genomic profiling. Nature Reviews Genetics 22(8): 483-501

  2. Blom EF, Ten Haaf K, Arenberg DA, et al. 2020. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States. Annals of the American Thoracic Society 17(2): 186-94

  3. National Comprehensive Cancer Network. 2022. NCCN Clinical Practice Guidelines in Oncology; Lung cancer screening: v1.2022 – October 26, 2021. Plymouth, PA: NCCN